Transcatheter Pulmonary Valve Market to grow at a CAGR of 5.6% during 2024-2028
The Transcatheter Pulmonary Valve Market is expected to grow at a CAGR of 5.6% during 2023 and 2028. During this period, the market is also expected to show a growth of USD 46.7 million. The Transcatheter Pulmonary Valve Market has experienced significant growth due to favorable reimbursement policies, particularly with the Centers for Medicare and Medicaid Services (CMS) coverage expansion for Transcatheter Aortic Valve Replacement (TAVR) in high-risk patients with severe aortic stenosis in 2012. This coverage, coupled with FDA approval, accelerated TAVR adoption as a less invasive alternative to open-heart surgery. However, initial coverage criteria were restrictive, necessitating evaluation by two cardiac surgeons and on-site surgical backup, thereby limiting market accessibility. Despite this, the overall trend for cardiac surgery reimbursement by Medicare has been declining over the past two decades.
Get more information on Transcatheter Pulmonary Valve Market by requesting a sample report
Technavio analysts predict that the Balloon-expanded subsegment will lead the Technology segment during 2024 and 2028 The balloon-expanded segment is poised for substantial growth in the global transcatheter pulmonary valve (TPV) market, surpassing the self-expanded segment in terms of revenue during the forecast period. This trend is driven by the expanding adoption of balloon-expanded TPVs, particularly in the treatment of conditions such as aortic stenosis and cardiovascular diseases, which are increasingly prevalent worldwide. Additionally, the streamlined procedures and expedited recovery times associated with balloon-expanded TPVs make them an attractive alternative for patients who may not be candidates for surgery due to health complications or frailty. These factors collectively contribute to the robust expansion of the balloon-expanded segment, thereby fueling the growth of the global transcatheter pulmonary valve market.
Here are the various ways based on which the market is segmented:
There are several factors that are causing the market to flourish rising incidence of cardiac diseases
Learn which are the obstacles that the market is experiencing in the way of its growth by accessing the free PDF report
The Transcatheter Pulmonary Valve (TPV) market is witnessing significant growth due to the increasing prevalence of heart procedures for congenital heart diseases and cardiovascular diseases. Congenital heart disease patients, particularly those with pulmonary valve regurgitation or stenosis, are prime candidates for innovative treatment options like TPV operations. These procedures offer advantages over traditional surgical procedures, including reduced healthcare spending, fewer complications, and shorter recovery times. TPVs include synthetic heart valves such as balloon-expandable and self-expanding options, which are delivered via specialized delivery catheters. The pediatric population, who often require multiple heart surgeries due to cardiac abnormalities, particularly benefit from these minimally invasive procedures. Cardiovascular medicine continues to evolve, with patient awareness programs playing a crucial role in early detection and intervention. Imaging techniques like 3D echocardiography and CT angiography aid in procedural planning and device selection. TPVs are revolutionizing heart health awareness and treatment for various cardiac conditions, offering hope for those suffering from pulmonary valve diseases.
In accordance with Technavio's market research, the Transcatheter Pulmonary Valve Market is a significant segment within the expansive Global Healthcare Equipment Market. This market encompasses entities involved in the research and development (R&D) of various product categories, such as capital equipment, instruments, implants, accessories, and consumables. The Global Healthcare Equipment Market's size is determined by the consolidated revenue generated by manufacturers of diagnostic equipment and devices utilized across diverse therapy areas. The Healthcare Equipment Industry is segmented into Devices, which includes advanced, differentiated, and clinically tested data-driven devices.
The Transcatheter Pulmonary Valve Market is experiencing significant growth, fueled by the rising incidence of cardiac diseases. Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.
Contacts
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
Safe and Secure SSL Encrypted